Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine
- PMID: 2879972
- DOI: 10.1016/s0140-6736(87)91968-4
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine
Abstract
Four patients with human-immuno-deficiency-virus-associated neurological disease were treated with 3'-azido-3'-deoxythymidine (AZT). Three (two with chronic dementia, and one with chronic dementia and peripheral neuropathy) improved as assessed by clinical examination, psychometric tests, nerve conduction studies, and/or positron emission tomography; there was no improvement in the fourth patient who presented with paraplegia. These results support the hypothesis that certain AIDS-virus-associated neurological abnormalities are reversible by antiretroviral chemotherapy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical